Introduction
Methods
Data and procedures
Measures
Analyses
Block | Predictors and rationale |
---|---|
1 | |
2 | Intervention effect: Since the PIASMA-study was a cRCT, analyses were adjusted for the intervention effect (time × group interaction) |
3 | |
4 | |
5 |
Results
Sample
Participant characteristics and predictors | |
---|---|
Age mean ± SD (n) | 81.55 ± 9.74 (146) |
Gender male %valid (n) | 34.9 (51) |
Diagnoses (multiple response) %of cases (n) | |
Musculoskeletal disorders | 41.8 (61) |
Tumour | 18.5 (27) |
Chronic wounds | 15.1 (22) |
Diabetes | 13.0 (19) |
Neuropathy | 11.6 (17) |
Pain intensity index [0–40] mean ± SD (n) | 18.49 ± 7.23 (146) |
Pain interference index [0–70] mean ± SD (n) | 29.61 ± 16.02 (146) |
MMSE score [10–30] mean ± SD (n) | 22.84 ± 4.90 (146) |
GDS score [0–15] mean ± SD (n) | 5.65 ± 3.66 (146) |
Outcome EQ-5D-3L ‘quality of life’ | |||
---|---|---|---|
EQ descriptive system (n) | No problems | Some problems | Extreme problems |
Mobility %valid (146) | 16.4 | 80.1 | 3.4 |
Self-care %valid (146) | 39.0 | 48.6 | 12.3 |
Usual activities %valid (146) | 31.5 | 50.7 | 17.8 |
Pain/discomfort %valid (146) | 2.7 | 75.3 | 21.9 |
Anxiety/depression %valid (146) | 54.8 | 40.4 | 4.8 |
EQ index [.02–1] mean ± SD (n) | .52 ± .24 (146) | ||
EQ VAS [0–100] mean ± SD (n) | 55.13 ± 21.51 (134) |
OLS models
Basic model | Final model | ||||||
---|---|---|---|---|---|---|---|
Tolerance | VIF | β | Tolerance | VIF | β | ||
1 | Constant (B) | .790 | .703 | ||||
Pain intensity index (0–40) | .677 | 1.476 | − .196* | .564 | 1.772 | .005 | |
Pain interference index (0–70) | .677 | 1.476 | − .334*** | .564 | 1.772 | − .446*** | |
2 | Constant (B) | .774 | .681 | ||||
Pain intensity index (0–40) | .674 | 1.484 | − .210* | .563 | 1.777 | − .010 | |
Pain interference index (0–70) | .677 | 1.476 | − .334*** | .564 | 1.772 | − .445*** | |
Intervention group (0/1) | .992 | 1.008 | .163* | .996 | 1.004 | .210* | |
3 | Constant (B) | .557 | – | ||||
Pain intensity index (0–40) | .674 | 1.484 | − .211* | – | – | – | |
Pain interference index (0–70) | .639 | 1.566 | − .294** | – | – | – | |
Intervention group (0/1) | .977 | 1.024 | .161* | – | – | – | |
Age (60–105) | .846 | 1.182 | .084 | Age and gender had no significant impact | |||
Male (0/1) | .877 | 1.140 | .167* | ||||
4 | Constant (B) | .604 | .739 | ||||
Pain intensity index (0–40) | .644 | 1.552 | − .175* | .555 | 1.800 | − .031 | |
Pain interference index (0–70) | .575 | 1.738 | − .325** | .564 | 1.774 | − .451*** | |
Intervention group (0/1) | .923 | 1.083 | .158* | .954 | 1.048 | .181* | |
Age (60–105) | .790 | 1.266 | .064 | – | – | – | |
Male (0/1) | .802 | 1.246 | .141a | – | – | – | |
Neuropathy (0/1) | .534 | 1.871 | .307** | Deleted because of missing correlation | |||
Tumour (0/1) | .751 | 1.332 | .101 | – | – | – | |
Musculoskeletal disorders (0/1) | .463 | 2.161 | .160 | – | – | – | |
Chronic wounds (0/1) | .663 | 1.508 | − .057 | – | – | – | |
Diabetes (0/1) | .927 | 1.079 | .008 | – | – | – | |
Number of diagnoses | .255 | 3.924 | − .260a | .924 | 1.082 | − .144 | |
5 | Constant (B) | .893 | .814 | ||||
Pain intensity index (0–40) | .632 | 1.582 | − .174* | .552 | 1.812 | − .064 | |
Pain interference index (0–70) | .551 | 1.814 | − .260** | .476 | 2.101 | − .274* | |
Intervention group (0/1) | .914 | 1.094 | .145* | .954 | 1.049 | .173* | |
Age (60–105) | .751 | 1.332 | .013 | – | – | – | |
Male (0/1) | .795 | 1.257 | .117 | – | – | – | |
Neuropathy (0/1) | .531 | 1.884 | .309** | Deleted because of missing correlation | |||
Tumour (0/1) | .713 | 1.403 | .088 | – | – | – | |
Musculoskeletal disorders (0/1) | .430 | 2.326 | .134 | – | – | – | |
Chronic wounds (0/1) | .660 | 1.515 | − .039 | – | – | – | |
Diabetes (0/1) | .915 | 1.093 | .035 | – | – | – | |
Number of diagnoses | .242 | 4.137 | − .281* | .918 | 1.089 | − .171* | |
MMSE score (0–30) | .875 | 1.143 | − .095 | – | – | – | |
GDS score (0–15) | .812 | 1.231 | − .246** | .785 | 1.273 | − .348*** | |
Condition index | 45.733 | 11.323 | |||||
Adjusted R2 | 0.344b | 0.324c | |||||
Durbin-Watson statistic | 1.635 | 2.133 | |||||
Studentized residual | All cases between − .3.0 and 3.0 | All cases between − 3.0 and 3.0 | |||||
Centered leverage value | 3 cases > .178 | All cases < .090 | |||||
Cook’s distance | All cases < 1.0 | All cases < 1.0 | |||||
Homoscedastic | Approved via scatterplot | Approved via scatterplot | |||||
Normally distributed | Approved via KS-test (p > .05) | Approved via KS-test (p > .05) | |||||
Linearity | Approved via scatterplot | Approved via scatterplot |